NASDAQ:SGEN
Delisted
Seattle Genetics Stock News
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen to Report First Quarter 2023 Financial Results on April 27, 2023
08:00am, Friday, 07'th Apr 2023
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023. Given the recently announced agree
Seagen's (SGEN) Padcev & Keytruda Combo Gets FDA Accelerated Nod
12:10pm, Tuesday, 04'th Apr 2023
The FDA grants accelerated approval to Seagen (SGEN) and partner, Astellas' combination therapy of Padcev with Merck's Keytruda for the treatment of first and second-line metastatic urothelial cancer.
Seagen founder Clay Siegall is back in biotech as CEO of Purdue University spinout
07:16pm, Wednesday, 22'nd Mar 2023
Clay Siegall, the Seagen founder who resigned last year following an arrest and allegations of domestic violence, is jumping back into the biotech world as CEO and president of Morphimmune.
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal
10:45am, Wednesday, 22'nd Mar 2023
Pfizer has been loading up on acquisitions to help strengthen its growth prospects. Acquiring Seagen is a big move for the company, but Pfizer isn't done with M&A yet.
3 Dividend Contenders to Buy Now for Long-Term Gains Later
07:01am, Wednesday, 22'nd Mar 2023
Dividend contenders are a group of companies that have increased the dividend they pay to shareholders for at least 10 years up to 24 years. There are currently over 360 such companies.
1 Top Healthcare Stock That Could Make You Richer in the Next Decade
09:15am, Sunday, 19'th Mar 2023
Pfizer's dividend has a decent yield right now, and its payout will likely grow. It'll be facing a few stiff headwinds soon, but they aren't relevant in the long term.
Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?
01:02pm, Friday, 17'th Mar 2023
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock?
Should Investors Consider Pfizer (PFE) or Seagen (SGEN) Stock After Acquisition
04:46pm, Tuesday, 14'th Mar 2023
Shares of Seagen (SGEN) popped 14% yesterday on news that Pfizer (PFE) would acquire the company for $43 billion. The deal values Seagen shares at $229 and 15% above current levels.
Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition?
11:45am, Tuesday, 14'th Mar 2023
Pfizer has been a stock in search of a catalyst all year long. The drugmaker's $43 billion acquisition of Seagen probably isn't the catalyst shareholders were hoping for.
Seagen (SGEN) Set to be Acquired by Pfizer for $43 B, Stock Up
10:44am, Tuesday, 14'th Mar 2023
Seagen is set to be acquired by the large-cap pharma company, Pfizer, at a valuation of $43 billion. The stock is up about 15% in response to the news.
Strength Seen in Seattle Genetics (SGEN): Can Its 14.5% Jump Turn into More Strength?
06:07am, Tuesday, 14'th Mar 2023
Seattle Genetics (SGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price incre
How Pfizer's $43 billion acquisition of Seagen could impact the biotech industry in Seattle
09:52pm, Monday, 13'th Mar 2023
Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed.
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
07:15pm, Monday, 13'th Mar 2023
Markets were mixed on a volatile day on Wall Street. Sanofi offered to buy Provention Bio at a price more than triple where the stock closed Friday.
Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions
05:34pm, Monday, 13'th Mar 2023
Last week ended on a hectic note
Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion
04:41pm, Monday, 13'th Mar 2023
Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pha
